November 2, 2021
In recent years late stage Pharma has begun to transition from a consumer of open source, and a sporadic creator, to a heavily invested collaborator on open source tools like R packages. In this short talk, James will discuss our recent focus on open source collaboration in post-competitive tools, and some important lessons we’ve learned.
R/Pharma, Virtual
---
title: Smoothing out our path to open source pan-pharma code collaboration
event: R/Pharma
event-url: rinpharma.com
location: Virtual
image: featured.png
abstract: |
In recent years late stage Pharma has begun to transition from a consumer of open source, and a sporadic creator, to a heavily invested collaborator on open source tools like R packages. In this short talk, James will discuss our recent focus on open source collaboration in post-competitive tools, and some important lessons we’ve learned.
date: "2021-11-02T13:00:00Z"
date_end: "2021-11-04T15:00:00Z"
slides: "/slides/2021_rinpharma.pdf"
categories: [R, Data Science, Open Source]
---
:::: {.columns}
<!--
::: {.column width="30%"}
::: {.callout-note icon=false}
## {{< fa video >}}
[Video]({{< meta video >}})
:::
:::
::: {.column width="5%"}
:::
-->
::: {.column width="30%"}
::: {.callout-note icon=false}
## {{< fa file-powerpoint >}}
[Slides]({{< meta slides >}})
:::
:::
::::
## Event
**[{{< meta event >}}]({{< meta event-url >}})**, {{< meta location >}}